81290-20-2 + 1829-26-1 = 887144-94-7 反应条件:1.1 Reagents: Cesium Fluoride Solvents: Acetonitrile; 21 H,25 °C 标题:Notification About The Explosive Properties Of Togni'S Reagent Ii And One Of Its Precursors 作者:Fiederling,Nikolaus; Haller,Jan; Schramm,Heiko 参考文献:Organic Process Research & Development 日期:2013 卷标:17(3) 页码:318-319]
81290-20-2 + 1829-26-1 = 887144-94-7 反应条件:1.1 Catalysts: Cesium Fluoride Solvents: Acetonitrile; 25 H,Rt 标题:Enantioselective Copper-Catalyzed Fukuyama Indole Synthesis From 2-Vinylphenyl Isocyanides 作者:Drennhaus,Till; Leifert,Dirk; Lammert,Jessika; Drennhaus,Jan Philipp; Bergander,Klaus; Et Al 参考文献:Journal Of The American Chemical Society 日期:2023 卷标:145(15) 页码:8665-8676]
专利号:US-2025282818-A1 优先权日:2022-04-25 标 题:Syrbactin macrolactams and unnatural analogs as proteasome inhibitors for the treatment of multiple myeloma and chemoenzymatic synthesis thereof 发明人:RENATA HANS; AMATUNI ALEXANDER; ADIBEKIAN ALEXANDER; SHUSTER ANTON 权利人:UNIV FLORIDA 摘要:One aspect of the invention is any compound, or salt thereof, described herein. Another aspect is a method of treating a disease, disorder, or symptom thereof, in a subject, comprising administration to the subject of a compound, or salt thereof, herein. Another aspect is a method of inhibiting a proteasome in a subject, comprising administration to the subject of a compound, or salt thereof, herein. Another aspect is a method of making a compound, or salt thereof, described herein using one or more reagents, chemical transformations, or chemical intermediate compounds as described herein.
专利号:CN-118755680-A 优先权日:2024-08-20 标题:Non-heme iron enzyme BsQueD or mutant thereof and application thereof in synthesis of ortho-trifluoromethyl substituted azide
专利号:CN-113582797-B 优先权日:2021-08-17 标 题:A method of copper-catalyzed synthesis of trifluoromethyl-1,3-enyne compounds
专利号:US-2023025807-A1 优先权日:2019-10-30 标题:Cd38 inhibitors 发明人:KULKARNI SANTOSH S; LAGU BHARAT; WU XINYUAN 权利人:MITOBRIDGE INC 摘要:The present invention is directed to a compound of Formula (I) or a pharmaceutically acceptable salt thereof. Compounds of Formula (I) are CD38 inhibitors, which can be used to treat a disease or condition in a subject that benefits from an increase in NAD + or to treat a mitochondrial disorder in a subject. Such disease or condition is a muscle structure disorder, a neuronal activation disorder, a muscle fatigue disorder, a muscle mass disorder, a metabolic disease, a cancer, a vascular disease, an ocular vascular disease, a muscular eye disease, or a renal disease. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 30 to 135; examples 1 to 61; table). Such an exemplary compound is e.g. N-((1r,4r)-4-(2-methoxyethoxy) cyclohexyl)-5-(thiazol-5-yl)-1H-indole-7-carboxamide (II).
专利号:CN-114702448-A 优先权日:2021-09-30 标题 :Synthesis method of trifluoromethylated tandem cyclization spiro-compound of cycloolefine